Bio News
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News | R&D
Pfizer Unveils $500M Biotech Fund
New program to support continued biotechnology innovation across a portfolio of clinical-stage biotechnology companiesContract Pharma Staff 06.02.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Emergent Joins U.S. Govt.’s COVID-19 Vax Acceleration Efforts in Landmark Deal
Public-private partnership for COVID-19 vaccine development and manufacturing valued at approximately $628 millionContract Pharma Staff 06.02.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
MilliporeSigma and Baylor Enter COVID-19 Vax Pact
Will focus on process development and improvements for manufacturing Baylor's Covid-19 vaccine candidatesContract Pharma Staff 06.02.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Facilities | Industry News
POINT Biopharma to Launch First US Manufacturing Facility
Next-gen oncology company plans long-term manufacturing growth, 100+ high-wage jobs in IndianapolisContract Pharma Staff 06.02.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Lilly, AbCellera Dose First Patients with COVID-19 Antibody
Phase 1 study of LY-CoV555 is the world's first study of a potential antibody treatment designed to fight COVID-19Contract Pharma Staff 06.01.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
CordenPharma & Moderna Extend Manufacturing Agreement
For the supply of lipid excipients to be used in Moderna's coronavirus vaccineContract Pharma Staff 05.29.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
IAVI and Merck Collaborate to Develop Vaccine Against SARS-CoV-2
Leverage complementary expertise & capabilities with rVSV technology to advance vaccine candidate.Contract Pharma Staff 05.27.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Merck and Ridgeback Bio Collaborate
Plan to advance development of novel antiviral candidate, EIDD-2801Contract Pharma Staff 05.27.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Ajinomoto Bio-Pharma Partners with Humanigen
Signs manufacturing agreement for Lenzilumab, a monoclonal antibodyContract Pharma Staff 05.27.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances | Drug Development | Industry News
Novasep, Lysogene Enter Gene Therapy Collaboration
For development and production of GM1 gangliosidosis gene therapy productContract Pharma Staff 05.27.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News
GSK Partners with Samsung Biologics
Inks $231 million deal to secure additional manufacturing capacity for biopharmaceutical portfolioContract Pharma Staff 05.27.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Rentschler Extends Collaboration with Genmab to U.S. Facility
Agreement provides flexible model to address Genmab’s development and manufacturing needs as programs advance in developmentContract Pharma Staff 05.27.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
Novavax Expands Large-Scale Global Manufacturing Capacity
Acquires Praha Vaccines in Czech Republic; annual operating capacity of over 1 billion doses of COVID-19 vaccine antigenContract Pharma Staff 05.27.20
-
Bio News | Breaking News | Clinical Trials | Collaborations & Alliances | Industry News
Montefiore, Einstein Test New Drug Combo to Conquer COVID-19
Researchers hope giving remdesivir along with a powerful anti-inflammatory could be the key to treating the most severe COVID-19 casesContract Pharma Staff 05.26.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
Merck to Acquire Themis
Will apply its vaccine development capabilities to SARS-CoV-2 vaccine program originated by Themis and Institut PasteurContract Pharma Staff 05.26.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Kindred, Vaxart Enter COVID-19 Vaccine Manufacturing Pact
Will make vaccine for clinical trials beginning in the second half of 2020Contract Pharma Staff 05.22.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Airway Therapeutics and Celonic Enter COVID-19 Collaboration
Will make AT-100 as promising new candidate for coronavirus, production expected to begin in JuneContract Pharma Staff 05.22.20
-
Bio News | Breaking News | Collaborations & Alliances | Drug Delivery | Industry News
Virpax Completes pre-IND Meeting with FDA
Epoladerm spray being developed with contract service company MedPharmContract Pharma Staff 05.22.20
-
Bio News | Bioanalytical Services | Breaking News | Industry News
Rapid Micro Biosystems Expands Testing Platform
Raises $120 million to accelerate global expansion of contaminant testing platform for pharmaceutical and vaccine manufacturingContract Pharma Staff 05.22.20
-
Bio News | Breaking News | Facilities | Industry News
WuXi Biologics Expands U.S. Footprint
Closes land deal to build 107,000-sq.-ft., state-of-the-art biologics production facility in Worcester, MA.Contract Pharma Staff 05.20.20
